Britt Meelby Jensen was labeled "the biotech queen": "Unfortunately, I think it demonstrates how there are still few female top executives in Denmark"

Atos Medical CEO Britt Meelby Jensen works hard and is curious about her projects, qualities which have brought her to the top of the life science industry – a place few women have gone before.

Britt Meelby Jensen | Photo: Atos Medical

When Britt Meelby Jensen started as CEO at Zealand Pharma in March 2015, she was dubbed "the new biotech queen" by the media. However, the executive was not happy about the title – not because of challenges she experiences as a woman in her everyday life, but because it shows that society still has a long way to go, she says.

"I think it reflects where we are as a society. Men don't often get titles like that – you wouldn't call Lars Fruergaard Jørgensen [CEO of Novo Nordisk, ed.] the 'pharma king'. Unfortunately, I think it demonstrates how there are still few female top executives in Denmark," Meelby Jensen says.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today